Skip to main content
Live

Market Intelligence

Page 126

Stocks·sp500-equal-weight

S&P 500 Equal Weight Hits All-Time High: Rotation or Mirage for Real Market Breadth?

Feb 7, 2026·8m
Stocks·dow-jones

Dow 50,000: Why the Oldest Index’s Milestone Is the Market’s Most Dangerous Mirage

Feb 7, 2026·8m
Stocks·ai

AI Bubble Trouble: Why Wall Street’s $650 Billion Tech Splurge Could Unravel the S&P 500

Feb 7, 2026·8m
Stocks·pharma

Old Economy’s Revenge: Why Pharma’s Earnings Blitz Is the Real Rotation Story of 2026

Feb 7, 2026·8m
Stocks·xlk

XLK’s Dead Calm: Why Tech’s Flatline Masks a Volatility Time Bomb for US Equities

Feb 7, 2026·8m
Stocks·market-breadth

Wall Street’s K-Shaped Schism: Why Market Breadth Is the New Alpha for 2026

Feb 7, 2026·8m
Stocks·reit

REITs Hold Steady as Wall Street Rotates: Is VNQ’s Calm Before the Storm or Value’s New Normal?

Feb 7, 2026·8m
Stocks·big-tech

Big Tech’s Earnings Hangover: Why Wall Street’s AI Obsession Is Fueling a Market Divide

Feb 7, 2026·8m
Stocks·sp500-equal-weight

S&P 500 Equal Weight Index Hits All-Time High as Wall Street’s Divide Grows Wider

Feb 7, 2026·8m
Stocks·ai

AI’s Capex Binge Leaves Software Stocks in the Cold as Investors Rotate Into Old-Economy Plays

Feb 7, 2026·8m
Stocks·utilities

AI’s Capex Binge Sends Shockwaves: Why Utilities Are Suddenly the Market’s Quiet Power Play

Feb 7, 2026·8m
Stocks·tech

Tech Sector’s Great Pause: XLK’s Flatline Masks a Brewing Storm in Software and AI

Feb 7, 2026·8m
Stocks·russell-2000

Russell 2000 Flatlines as Investors Ditch Growth for Value: Is Small Cap Stagnation Here to Stay?

Feb 7, 2026·8m
Stocks·big-pharma

Obesity Drug Wars: Big Pharma’s Next Growth Engine or Just a High-Calorie Hype Cycle?

Feb 7, 2026·8m
Stocks·big-tech

Big Tech’s Earnings Hangover: Why Wall Street Is Bracing for a Volatility Revival

Feb 7, 2026·8m